Bram Rochwerg to Evidence-Based Medicine
This is a "connection" page, showing publications Bram Rochwerg has written about Evidence-Based Medicine.
Connection Strength
0.307
-
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018 11 27; 2(22):3317-3359.
Score: 0.073
-
GRADE approach to rate the certainty from a network meta-analysis: avoiding spurious judgments of imprecision in sparse networks. J Clin Epidemiol. 2019 01; 105:60-67.
Score: 0.072
-
Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach. Health Qual Life Outcomes. 2017 May 02; 15(1):52.
Score: 0.066
-
Drug treatments for covid-19: living systematic review and network meta-analysis. BMJ. 2020 07 30; 370:m2980.
Score: 0.021
-
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. CMAJ. 2020 05 19; 192(20):E536-E545.
Score: 0.020
-
European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD. Eur Respir J. 2019 09; 54(3).
Score: 0.019
-
Development of the summary of findings table for network meta-analysis. J Clin Epidemiol. 2019 11; 115:1-13.
Score: 0.019
-
Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017. Intensive Care Med. 2017 Dec; 43(12):1751-1763.
Score: 0.017